Last reviewed · How we verify

NCT03787875

Impact of Periodontal Treatment on the RANKL/OPG Ratio in Crevicular Fluid

Completed Last updated 26 December 2018
What this trial tests

trial testing periodontal treatment in Periodontal Diseases in 40 participants. Completed in 6 November 2016.

Timeline
2 February 2016
Primary endpoint
5 June 2016
6 November 2016

Quick facts

Lead sponsorUniversity of Valencia
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date2 February 2016
Primary completion5 June 2016
Estimated completion6 November 2016

Drugs / interventions tested

Conditions studied

Sponsor

University of Valencia

Who can join

Adults 40 to 60, any sex, with Periodontal Diseases or Biomarkers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: Alveolar resorption is one of the most important events in periodontitis. Osteoclast activity is regulated by the ratio between receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG). The aim of this study was to evaluate changes in the RANKL/OPG ratio in crevicular fluid after periodontal treatment. Material and methods: A total of 15 patients with periodontitis were included in the study group. Samples were collected from an area with active periodontitis and a healthy area. The RANKL and OPG levels were measured before and after periodontal scaling and root planing (SRP) treatment. The study group was compared to the control group, which included 10 patients without periodontitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.
    López Roldán A, García Giménez JL, Alpiste Illueca F. · · 2020 · cited 25× · PMID 31986169 · DOI 10.1371/journal.pone.0227757

Verify or expand the search:

Other trials of periodontal treatment

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other University of Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03787875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing